Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07518004 · ClinicalTrials.gov registry record · NA
ROME GS System Study
A NA study, sponsored by Senseonics.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07518004 is a NA study that is actively recruiting participants, run by Senseonics. The registered enrollment target is 60 participants.
The verdict
NCT07518004, a NA study, is actively recruiting participants, sponsored by Senseonics.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.
Interventions
- DEVICE Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-12 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07518004
The ClinicalTrials.gov registry entry for NCT07518004 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Senseonics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring System is the first listed.
NCT07518004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07518004 about?
NCT07518004 is a clinical study titled "ROME GS System Study". The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.
What is the current status of trial NCT07518004?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-12. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07518004?
The interventions under investigation include: Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT07518004?
This trial is sponsored by Senseonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.